Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy
about
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerMicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancerSFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancerPePr: a peak-calling prioritization pipeline to identify consistent or differential peaks from replicated ChIP-Seq data.DNA methylation profile and expression of surfactant protein A2 gene in lung cancer.Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosisProfiling Analysis of Histone Modifications and Gene Expression in Lewis Lung Carcinoma Murine Cells Resistant to Anti-VEGF Treatment.miR-1290 is a potential prognostic biomarker in non-small cell lung cancerConcerted changes in transcriptional regulation of genes involved in DNA methylation, demethylation, and folate-mediated one-carbon metabolism pathways in the NCI-60 cancer cell line panel in response to cancer drug treatmentSynergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression.Role of microRNA-4458 in patients with non-small-cell lung cancerEpigenetics in immune-mediated pulmonary diseases.Targeting epigenetic regulators for cancer therapy.Mitochondrial dynamics: biology and therapy in lung cancer.Epigenetic alterations in cancer and personalized cancer treatment.The role of oncolytic virus immunotherapies to subvert cancer immune evasion.Epigenetic therapy for solid tumors: from bench science to clinical trials.A new insight on reciprocal relationship between microRNA expression and epigenetic modifications in human lung cancer.INO80 is required for oncogenic transcription and tumor growth in non-small cell lung cancer.MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription.A histone deacetylase inhibitor enhances expression of genes inhibiting Wnt pathway and augments activity of DNA demethylation reagent against nonsmall-cell lung cancer.MicroRNA-146a rs2910164 polymorphism is associated with susceptibility to non-small cell lung cancer in the Chinese population.A meta-analytic review of the association between two common SNPs in miRNAs and lung cancer susceptibility.
P2860
Q26801108-6ED75CBE-BC30-4BC9-98DF-9518EEA5D61FQ26849525-A9286B5F-648B-4856-AF3F-57DFAB736346Q28277902-F6D84F01-3C81-4CC1-968E-08B78920155BQ30828757-0D2FF236-EB05-4CF4-8673-BB71076520DDQ35106906-670F3FE9-2270-4FDA-8DD8-FA78F0635D86Q35147669-A1A8F6B1-F6C0-45F2-8D4F-5F2243DBA43BQ36064738-7C57828C-B0D6-439D-8EF5-4A7ED34C01B0Q36138340-14A08F7E-A881-4D02-AC46-5D557CB237B8Q37035513-A625D767-FA95-47DC-98ED-A3FE54BA5EA3Q37190106-57D7F44C-1B41-4E90-B238-EB2EE363F7B3Q37407264-1AF6E0C0-8526-47BE-A710-32ED5473850EQ38163413-3C70D22B-35AB-4B7D-8AD8-CD03539E92F9Q38191266-1F913D33-CF99-405F-BDAD-45F3C76A16B0Q38198085-AF308991-2496-4C45-882F-A9624548DF51Q38319591-CA383C70-FF41-4755-8856-30FA5101E7FFQ38357137-B0C1FA78-84BE-45AE-A0B9-788164F07AD0Q38459836-3E248684-E43F-40B4-A80D-36A0FDDFF568Q38688031-F42B36A9-1450-4296-8A7B-664527DC4CFBQ38745550-0F5700C0-41A3-4CA1-AFE3-AA0062F699A4Q38902929-C27B7475-695A-49A3-8555-30236501B1A8Q48199426-60A55113-EBB6-455E-9606-049218C05E8AQ54193793-719BA67B-0D8E-4A44-A1E9-5854BED09345Q55016438-FC8B800C-9B2E-4243-BEA7-47034B2B7EF7
P2860
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy
@ast
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy
@en
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy
@nl
type
label
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy
@ast
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy
@en
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy
@nl
altLabel
Targeting the Epigenome in Lung Cancer: Expanding Approaches to Epigenetic Therapy
@en
prefLabel
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy
@ast
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy
@en
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy
@nl
P2093
P2860
P50
P3181
P356
P1476
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy
@en
P2093
David Schrump
Marko Jakopovic
Susan E Bates
P2860
P3181
P356
10.3389/FONC.2013.00261
P407
P577
2013-01-01T00:00:00Z